nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Rash macular—Ifosfamide—germ cell cancer	0.0324	0.0324	CcSEcCtD
Gadoteridol—Generalised oedema—Cisplatin—germ cell cancer	0.0192	0.0192	CcSEcCtD
Gadoteridol—Stupor—Ifosfamide—germ cell cancer	0.0178	0.0178	CcSEcCtD
Gadoteridol—Wheezing—Bleomycin—germ cell cancer	0.0151	0.0151	CcSEcCtD
Gadoteridol—Cyanosis—Etoposide—germ cell cancer	0.0148	0.0148	CcSEcCtD
Gadoteridol—Laryngospasm—Etoposide—germ cell cancer	0.014	0.014	CcSEcCtD
Gadoteridol—Neck stiffness—Methotrexate—germ cell cancer	0.0132	0.0132	CcSEcCtD
Gadoteridol—Tingling sensation—Etoposide—germ cell cancer	0.013	0.013	CcSEcCtD
Gadoteridol—Salivary hypersecretion—Ifosfamide—germ cell cancer	0.0129	0.0129	CcSEcCtD
Gadoteridol—Depressed level of consciousness—Ifosfamide—germ cell cancer	0.0128	0.0128	CcSEcCtD
Gadoteridol—Urinary incontinence—Ifosfamide—germ cell cancer	0.0128	0.0128	CcSEcCtD
Gadoteridol—Apnoea—Etoposide—germ cell cancer	0.0124	0.0124	CcSEcCtD
Gadoteridol—Nuchal rigidity—Methotrexate—germ cell cancer	0.0121	0.0121	CcSEcCtD
Gadoteridol—Cardiovascular disorder—Etoposide—germ cell cancer	0.0119	0.0119	CcSEcCtD
Gadoteridol—Wheezing—Cisplatin—germ cell cancer	0.0111	0.0111	CcSEcCtD
Gadoteridol—Fluid retention—Cisplatin—germ cell cancer	0.0109	0.0109	CcSEcCtD
Gadoteridol—Rash maculo-papular—Etoposide—germ cell cancer	0.00953	0.00953	CcSEcCtD
Gadoteridol—Cardiac arrest—Ifosfamide—germ cell cancer	0.00917	0.00917	CcSEcCtD
Gadoteridol—Dysphagia—Dactinomycin—germ cell cancer	0.00909	0.00909	CcSEcCtD
Gadoteridol—Cyanosis—Methotrexate—germ cell cancer	0.00888	0.00888	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00859	0.00859	CcSEcCtD
Gadoteridol—Stupor—Methotrexate—germ cell cancer	0.00841	0.00841	CcSEcCtD
Gadoteridol—Face oedema—Cisplatin—germ cell cancer	0.00802	0.00802	CcSEcCtD
Gadoteridol—Gingivitis—Methotrexate—germ cell cancer	0.008	0.008	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00787	0.00787	CcSEcCtD
Gadoteridol—Ill-defined disorder—Vinblastine—germ cell cancer	0.00746	0.00746	CcSEcCtD
Gadoteridol—Apnoea—Methotrexate—germ cell cancer	0.00741	0.00741	CcSEcCtD
Gadoteridol—Malaise—Vinblastine—germ cell cancer	0.00725	0.00725	CcSEcCtD
Gadoteridol—Flushing—Bleomycin—germ cell cancer	0.00724	0.00724	CcSEcCtD
Gadoteridol—Cardiac arrest—Etoposide—germ cell cancer	0.00724	0.00724	CcSEcCtD
Gadoteridol—Musculoskeletal stiffness—Methotrexate—germ cell cancer	0.007	0.007	CcSEcCtD
Gadoteridol—Convulsion—Vinblastine—germ cell cancer	0.00697	0.00697	CcSEcCtD
Gadoteridol—Hypertension—Vinblastine—germ cell cancer	0.00694	0.00694	CcSEcCtD
Gadoteridol—Erythema—Bleomycin—germ cell cancer	0.00679	0.00679	CcSEcCtD
Gadoteridol—Bradycardia—Ifosfamide—germ cell cancer	0.00679	0.00679	CcSEcCtD
Gadoteridol—Discomfort—Vinblastine—germ cell cancer	0.00676	0.00676	CcSEcCtD
Gadoteridol—Flushing—Dactinomycin—germ cell cancer	0.00675	0.00675	CcSEcCtD
Gadoteridol—Dysphagia—Etoposide—germ cell cancer	0.00658	0.00658	CcSEcCtD
Gadoteridol—Erythema—Dactinomycin—germ cell cancer	0.00633	0.00633	CcSEcCtD
Gadoteridol—Ill-defined disorder—Bleomycin—germ cell cancer	0.0063	0.0063	CcSEcCtD
Gadoteridol—Tinnitus—Ifosfamide—germ cell cancer	0.00622	0.00622	CcSEcCtD
Gadoteridol—Flushing—Ifosfamide—germ cell cancer	0.00619	0.00619	CcSEcCtD
Gadoteridol—Malaise—Bleomycin—germ cell cancer	0.00613	0.00613	CcSEcCtD
Gadoteridol—Depressed level of consciousness—Methotrexate—germ cell cancer	0.00607	0.00607	CcSEcCtD
Gadoteridol—Cough—Bleomycin—germ cell cancer	0.00593	0.00593	CcSEcCtD
Gadoteridol—Paraesthesia—Vinblastine—germ cell cancer	0.00589	0.00589	CcSEcCtD
Gadoteridol—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00588	0.00588	CcSEcCtD
Gadoteridol—Bradycardia—Cisplatin—germ cell cancer	0.00585	0.00585	CcSEcCtD
Gadoteridol—Erythema—Ifosfamide—germ cell cancer	0.00581	0.00581	CcSEcCtD
Gadoteridol—Chest pain—Bleomycin—germ cell cancer	0.00578	0.00578	CcSEcCtD
Gadoteridol—Discomfort—Bleomycin—germ cell cancer	0.00571	0.00571	CcSEcCtD
Gadoteridol—Malaise—Dactinomycin—germ cell cancer	0.00571	0.00571	CcSEcCtD
Gadoteridol—Pain—Vinblastine—germ cell cancer	0.00561	0.00561	CcSEcCtD
Gadoteridol—Anaphylactic shock—Bleomycin—germ cell cancer	0.00554	0.00554	CcSEcCtD
Gadoteridol—Oedema—Bleomycin—germ cell cancer	0.00554	0.00554	CcSEcCtD
Gadoteridol—Feeling abnormal—Vinblastine—germ cell cancer	0.00541	0.00541	CcSEcCtD
Gadoteridol—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00539	0.00539	CcSEcCtD
Gadoteridol—Tinnitus—Cisplatin—germ cell cancer	0.00536	0.00536	CcSEcCtD
Gadoteridol—Flushing—Cisplatin—germ cell cancer	0.00534	0.00534	CcSEcCtD
Gadoteridol—Discomfort—Dactinomycin—germ cell cancer	0.00533	0.00533	CcSEcCtD
Gadoteridol—Malaise—Ifosfamide—germ cell cancer	0.00523	0.00523	CcSEcCtD
Gadoteridol—Abdominal pain—Vinblastine—germ cell cancer	0.00519	0.00519	CcSEcCtD
Gadoteridol—Hypotension—Bleomycin—germ cell cancer	0.00518	0.00518	CcSEcCtD
Gadoteridol—Oedema—Dactinomycin—germ cell cancer	0.00517	0.00517	CcSEcCtD
Gadoteridol—Cough—Ifosfamide—germ cell cancer	0.00507	0.00507	CcSEcCtD
Gadoteridol—Convulsion—Ifosfamide—germ cell cancer	0.00503	0.00503	CcSEcCtD
Gadoteridol—Hypertension—Ifosfamide—germ cell cancer	0.00501	0.00501	CcSEcCtD
Gadoteridol—Erythema—Cisplatin—germ cell cancer	0.005	0.005	CcSEcCtD
Gadoteridol—Paraesthesia—Bleomycin—germ cell cancer	0.00498	0.00498	CcSEcCtD
Gadoteridol—Dyspnoea—Bleomycin—germ cell cancer	0.00494	0.00494	CcSEcCtD
Gadoteridol—Chest pain—Ifosfamide—germ cell cancer	0.00494	0.00494	CcSEcCtD
Gadoteridol—Flushing—Etoposide—germ cell cancer	0.00489	0.00489	CcSEcCtD
Gadoteridol—Discomfort—Ifosfamide—germ cell cancer	0.00488	0.00488	CcSEcCtD
Gadoteridol—Hypersensitivity—Vinblastine—germ cell cancer	0.00484	0.00484	CcSEcCtD
Gadoteridol—Pain—Bleomycin—germ cell cancer	0.00474	0.00474	CcSEcCtD
Gadoteridol—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00474	0.00474	CcSEcCtD
Gadoteridol—Oedema—Ifosfamide—germ cell cancer	0.00474	0.00474	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00471	0.00471	CcSEcCtD
Gadoteridol—Tremor—Cisplatin—germ cell cancer	0.00469	0.00469	CcSEcCtD
Gadoteridol—Ill-defined disorder—Cisplatin—germ cell cancer	0.00464	0.00464	CcSEcCtD
Gadoteridol—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00458	0.00458	CcSEcCtD
Gadoteridol—Feeling abnormal—Bleomycin—germ cell cancer	0.00457	0.00457	CcSEcCtD
Gadoteridol—Malaise—Cisplatin—germ cell cancer	0.00451	0.00451	CcSEcCtD
Gadoteridol—Diarrhoea—Vinblastine—germ cell cancer	0.00449	0.00449	CcSEcCtD
Gadoteridol—Dysgeusia—Etoposide—germ cell cancer	0.00449	0.00449	CcSEcCtD
Gadoteridol—Hypotension—Ifosfamide—germ cell cancer	0.00443	0.00443	CcSEcCtD
Gadoteridol—Pain—Dactinomycin—germ cell cancer	0.00442	0.00442	CcSEcCtD
Gadoteridol—Urticaria—Bleomycin—germ cell cancer	0.0044	0.0044	CcSEcCtD
Gadoteridol—Body temperature increased—Bleomycin—germ cell cancer	0.00438	0.00438	CcSEcCtD
Gadoteridol—Dizziness—Vinblastine—germ cell cancer	0.00434	0.00434	CcSEcCtD
Gadoteridol—Convulsion—Cisplatin—germ cell cancer	0.00434	0.00434	CcSEcCtD
Gadoteridol—Feeling abnormal—Dactinomycin—germ cell cancer	0.00426	0.00426	CcSEcCtD
Gadoteridol—Paraesthesia—Ifosfamide—germ cell cancer	0.00425	0.00425	CcSEcCtD
Gadoteridol—Ill-defined disorder—Etoposide—germ cell cancer	0.00425	0.00425	CcSEcCtD
Gadoteridol—Anxiety—Cisplatin—germ cell cancer	0.00425	0.00425	CcSEcCtD
Gadoteridol—Dyspnoea—Ifosfamide—germ cell cancer	0.00422	0.00422	CcSEcCtD
Gadoteridol—Discomfort—Cisplatin—germ cell cancer	0.00421	0.00421	CcSEcCtD
Gadoteridol—Vomiting—Vinblastine—germ cell cancer	0.00417	0.00417	CcSEcCtD
Gadoteridol—Malaise—Etoposide—germ cell cancer	0.00413	0.00413	CcSEcCtD
Gadoteridol—Headache—Vinblastine—germ cell cancer	0.00411	0.00411	CcSEcCtD
Gadoteridol—Abdominal pain—Dactinomycin—germ cell cancer	0.00409	0.00409	CcSEcCtD
Gadoteridol—Body temperature increased—Dactinomycin—germ cell cancer	0.00409	0.00409	CcSEcCtD
Gadoteridol—Anaphylactic shock—Cisplatin—germ cell cancer	0.00408	0.00408	CcSEcCtD
Gadoteridol—Oedema—Cisplatin—germ cell cancer	0.00408	0.00408	CcSEcCtD
Gadoteridol—Hypersensitivity—Bleomycin—germ cell cancer	0.00408	0.00408	CcSEcCtD
Gadoteridol—Pain—Ifosfamide—germ cell cancer	0.00405	0.00405	CcSEcCtD
Gadoteridol—Loss of consciousness—Etoposide—germ cell cancer	0.00403	0.00403	CcSEcCtD
Gadoteridol—Cough—Etoposide—germ cell cancer	0.004	0.004	CcSEcCtD
Gadoteridol—Convulsion—Etoposide—germ cell cancer	0.00397	0.00397	CcSEcCtD
Gadoteridol—Hypertension—Etoposide—germ cell cancer	0.00396	0.00396	CcSEcCtD
Gadoteridol—Hyperhidrosis—Cisplatin—germ cell cancer	0.00395	0.00395	CcSEcCtD
Gadoteridol—Pruritus—Bleomycin—germ cell cancer	0.00392	0.00392	CcSEcCtD
Gadoteridol—Feeling abnormal—Ifosfamide—germ cell cancer	0.0039	0.0039	CcSEcCtD
Gadoteridol—Chest pain—Etoposide—germ cell cancer	0.0039	0.0039	CcSEcCtD
Gadoteridol—Nausea—Vinblastine—germ cell cancer	0.0039	0.0039	CcSEcCtD
Gadoteridol—Discomfort—Etoposide—germ cell cancer	0.00386	0.00386	CcSEcCtD
Gadoteridol—Hypotension—Cisplatin—germ cell cancer	0.00382	0.00382	CcSEcCtD
Gadoteridol—Hypersensitivity—Dactinomycin—germ cell cancer	0.00381	0.00381	CcSEcCtD
Gadoteridol—Urticaria—Ifosfamide—germ cell cancer	0.00376	0.00376	CcSEcCtD
Gadoteridol—Body temperature increased—Ifosfamide—germ cell cancer	0.00375	0.00375	CcSEcCtD
Gadoteridol—Abdominal pain—Ifosfamide—germ cell cancer	0.00375	0.00375	CcSEcCtD
Gadoteridol—Anaphylactic shock—Etoposide—germ cell cancer	0.00374	0.00374	CcSEcCtD
Gadoteridol—Paraesthesia—Cisplatin—germ cell cancer	0.00367	0.00367	CcSEcCtD
Gadoteridol—Dyspnoea—Cisplatin—germ cell cancer	0.00364	0.00364	CcSEcCtD
Gadoteridol—Hyperhidrosis—Etoposide—germ cell cancer	0.00362	0.00362	CcSEcCtD
Gadoteridol—Diarrhoea—Dactinomycin—germ cell cancer	0.00354	0.00354	CcSEcCtD
Gadoteridol—Vomiting—Bleomycin—germ cell cancer	0.00352	0.00352	CcSEcCtD
Gadoteridol—Hypotension—Etoposide—germ cell cancer	0.0035	0.0035	CcSEcCtD
Gadoteridol—Rash—Bleomycin—germ cell cancer	0.0035	0.0035	CcSEcCtD
Gadoteridol—Pain—Cisplatin—germ cell cancer	0.00349	0.00349	CcSEcCtD
Gadoteridol—Dermatitis—Bleomycin—germ cell cancer	0.00349	0.00349	CcSEcCtD
Gadoteridol—Hypersensitivity—Ifosfamide—germ cell cancer	0.00349	0.00349	CcSEcCtD
Gadoteridol—Sweating—Methotrexate—germ cell cancer	0.00337	0.00337	CcSEcCtD
Gadoteridol—Feeling abnormal—Cisplatin—germ cell cancer	0.00337	0.00337	CcSEcCtD
Gadoteridol—Paraesthesia—Etoposide—germ cell cancer	0.00336	0.00336	CcSEcCtD
Gadoteridol—Pruritus—Ifosfamide—germ cell cancer	0.00335	0.00335	CcSEcCtD
Gadoteridol—Dyspnoea—Etoposide—germ cell cancer	0.00334	0.00334	CcSEcCtD
Gadoteridol—Nausea—Bleomycin—germ cell cancer	0.00329	0.00329	CcSEcCtD
Gadoteridol—Vomiting—Dactinomycin—germ cell cancer	0.00329	0.00329	CcSEcCtD
Gadoteridol—Rash—Dactinomycin—germ cell cancer	0.00326	0.00326	CcSEcCtD
Gadoteridol—Diarrhoea—Ifosfamide—germ cell cancer	0.00324	0.00324	CcSEcCtD
Gadoteridol—Body temperature increased—Cisplatin—germ cell cancer	0.00323	0.00323	CcSEcCtD
Gadoteridol—Pain—Etoposide—germ cell cancer	0.0032	0.0032	CcSEcCtD
Gadoteridol—Dizziness—Ifosfamide—germ cell cancer	0.00313	0.00313	CcSEcCtD
Gadoteridol—Feeling abnormal—Etoposide—germ cell cancer	0.00308	0.00308	CcSEcCtD
Gadoteridol—Nausea—Dactinomycin—germ cell cancer	0.00307	0.00307	CcSEcCtD
Gadoteridol—Vomiting—Ifosfamide—germ cell cancer	0.00301	0.00301	CcSEcCtD
Gadoteridol—Hypersensitivity—Cisplatin—germ cell cancer	0.00301	0.00301	CcSEcCtD
Gadoteridol—Rash—Ifosfamide—germ cell cancer	0.00299	0.00299	CcSEcCtD
Gadoteridol—Dermatitis—Ifosfamide—germ cell cancer	0.00298	0.00298	CcSEcCtD
Gadoteridol—Urticaria—Etoposide—germ cell cancer	0.00297	0.00297	CcSEcCtD
Gadoteridol—Abdominal pain—Etoposide—germ cell cancer	0.00296	0.00296	CcSEcCtD
Gadoteridol—Body temperature increased—Etoposide—germ cell cancer	0.00296	0.00296	CcSEcCtD
Gadoteridol—Tinnitus—Methotrexate—germ cell cancer	0.00294	0.00294	CcSEcCtD
Gadoteridol—Nausea—Ifosfamide—germ cell cancer	0.00281	0.00281	CcSEcCtD
Gadoteridol—Diarrhoea—Cisplatin—germ cell cancer	0.00279	0.00279	CcSEcCtD
Gadoteridol—Hypersensitivity—Etoposide—germ cell cancer	0.00276	0.00276	CcSEcCtD
Gadoteridol—Erythema—Methotrexate—germ cell cancer	0.00275	0.00275	CcSEcCtD
Gadoteridol—Dysgeusia—Methotrexate—germ cell cancer	0.00269	0.00269	CcSEcCtD
Gadoteridol—Pruritus—Etoposide—germ cell cancer	0.00265	0.00265	CcSEcCtD
Gadoteridol—Vomiting—Cisplatin—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gadoteridol—Rash—Cisplatin—germ cell cancer	0.00258	0.00258	CcSEcCtD
Gadoteridol—Dermatitis—Cisplatin—germ cell cancer	0.00257	0.00257	CcSEcCtD
Gadoteridol—Diarrhoea—Etoposide—germ cell cancer	0.00256	0.00256	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methotrexate—germ cell cancer	0.00255	0.00255	CcSEcCtD
Gadoteridol—Malaise—Methotrexate—germ cell cancer	0.00248	0.00248	CcSEcCtD
Gadoteridol—Dizziness—Etoposide—germ cell cancer	0.00247	0.00247	CcSEcCtD
Gadoteridol—Nausea—Cisplatin—germ cell cancer	0.00243	0.00243	CcSEcCtD
Gadoteridol—Cough—Methotrexate—germ cell cancer	0.0024	0.0024	CcSEcCtD
Gadoteridol—Convulsion—Methotrexate—germ cell cancer	0.00238	0.00238	CcSEcCtD
Gadoteridol—Vomiting—Etoposide—germ cell cancer	0.00238	0.00238	CcSEcCtD
Gadoteridol—Rash—Etoposide—germ cell cancer	0.00236	0.00236	CcSEcCtD
Gadoteridol—Dermatitis—Etoposide—germ cell cancer	0.00236	0.00236	CcSEcCtD
Gadoteridol—Headache—Etoposide—germ cell cancer	0.00234	0.00234	CcSEcCtD
Gadoteridol—Chest pain—Methotrexate—germ cell cancer	0.00234	0.00234	CcSEcCtD
Gadoteridol—Discomfort—Methotrexate—germ cell cancer	0.00231	0.00231	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methotrexate—germ cell cancer	0.00224	0.00224	CcSEcCtD
Gadoteridol—Nausea—Etoposide—germ cell cancer	0.00222	0.00222	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methotrexate—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gadoteridol—Hypotension—Methotrexate—germ cell cancer	0.00209	0.00209	CcSEcCtD
Gadoteridol—Paraesthesia—Methotrexate—germ cell cancer	0.00201	0.00201	CcSEcCtD
Gadoteridol—Dyspnoea—Methotrexate—germ cell cancer	0.002	0.002	CcSEcCtD
Gadoteridol—Pain—Methotrexate—germ cell cancer	0.00192	0.00192	CcSEcCtD
Gadoteridol—Feeling abnormal—Methotrexate—germ cell cancer	0.00185	0.00185	CcSEcCtD
Gadoteridol—Urticaria—Methotrexate—germ cell cancer	0.00178	0.00178	CcSEcCtD
Gadoteridol—Abdominal pain—Methotrexate—germ cell cancer	0.00177	0.00177	CcSEcCtD
Gadoteridol—Body temperature increased—Methotrexate—germ cell cancer	0.00177	0.00177	CcSEcCtD
Gadoteridol—Hypersensitivity—Methotrexate—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gadoteridol—Pruritus—Methotrexate—germ cell cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Diarrhoea—Methotrexate—germ cell cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Dizziness—Methotrexate—germ cell cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Vomiting—Methotrexate—germ cell cancer	0.00143	0.00143	CcSEcCtD
Gadoteridol—Rash—Methotrexate—germ cell cancer	0.00141	0.00141	CcSEcCtD
Gadoteridol—Dermatitis—Methotrexate—germ cell cancer	0.00141	0.00141	CcSEcCtD
Gadoteridol—Headache—Methotrexate—germ cell cancer	0.0014	0.0014	CcSEcCtD
Gadoteridol—Nausea—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
